Robin Barbour

16.9k citations
45 papers · 14.0k · 6 hit papers · h-index 31

Impact in

  • Physiology top 0.05%
    • Alzheimer's disease research and treatments
  • Neurology top 0.1%
    • Neuroinflammation and Neurodegeneration Mechanisms
    • Parkinson's Disease Mechanisms and Treatments

Papers in

    • Alzheimer's disease research and treatments 30
    • Parkinson's Disease Mechanisms and Treatments 7
    • Neuroinflammation and Neurodegeneration Mechanisms 5

Robin Barbour

44 papers receiving 13.3k citations

Robin Barbour's Hit Papers

Phosphorylation of Ser-129 Is the Dominant Pathological Modification of α-Synuclein in Familial and Sporadic Lewy Body Disease 2006 · 1.2k citations
1.2k0+10+20Years since publication50010001.5k2.0k2.5k

Peers

Robin Barbour
Comparison fields: 5 of 124
  • Physiology 10.1k
  • Neurology 2.9k
  • Biological Psychiatry 705
  • Neurology 2.4k
  • Pharmacology 2.6k
Replace Kelly R. Bales with:
Kelly R. Bales United States
Dora Games United States
Karen H. Ashe United States
Kelly Johnson‐Wood United States
Linda H. Younkin United States
Christopher B. Eckman United States
Mikio Shoji Japan
Marc H. Mercken Belgium
Lisa McConlogue United States
Nobuhisa Iwata Japan
Robin Barbour relative to Kelly R. Bales United States Kelly R. Bales's profile →
Citations per field
00.5×1.6×
Kelly R. Bales · 1×
Citations per year

Countries citing papers authored by Robin Barbour

Since Specialization
Citations

This map shows the geographic impact of Robin Barbour's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robin Barbour with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robin Barbour more than expected).

Fields of papers citing papers by Robin Barbour

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robin Barbour. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robin Barbour. The network helps show where Robin Barbour may publish in the future.

Co-authors

The 25 scholars most cited alongside Robin Barbour, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Robin Barbour Line = papers co-authored together Robin Barbour links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse
Hit paper breakdown →
19992715
2
Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein
Hit paper breakdown →
19952177
3
Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease
Hit paper breakdown →
20001741
4
Purification and cloning of amyloid precursor protein β-secretase from human brain
Hit paper breakdown →
19991407
5
Phosphorylation of Ser-129 Is the Dominant Pathological Modification of α-Synuclein in Familial and Sporadic Lewy Body Disease
Hit paper breakdown →
20061192
6
Reduction of β‐amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's disease
Hit paper breakdown →
1995620
7 1997581
8 1993484
9 2008427
10 2003352
11 1995314
12 2014271
13 1995202
14 2005144
15 2004141
16 1992129
17 2008108
18 202199
19 202196
20 200387

About Robin Barbour

Robin Barbour is a scholar working on Physiology, Neurology, Neurology, Molecular Biology and Computational Theory and Mathematics, having authored 45 papers that have together received 14.0k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (30 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (10 papers), Prion Diseases and Protein Misfolding (8 papers), Parkinson's Disease Mechanisms and Treatments (7 papers), Computational Drug Discovery Methods (6 papers), Neuroinflammation and Neurodegeneration Mechanisms (5 papers), Cholinesterase and Neurodegenerative Diseases (5 papers) and Drug Transport and Resistance Mechanisms (5 papers). The work is most often cited by research in Physiology (10.1k citations), Neurology (2.9k citations), Biological Psychiatry (705 citations), Neurology (2.4k citations) and Pharmacology (2.6k citations). Robin Barbour has collaborated with scholars based in United States, Germany and Switzerland. Frequent co-authors include Peter A. Seubert, Dale Schenk, Ivan M. Lieberburg, Dora Games, Ruth N. Motter, Kelly Johnson‐Wood, John P. E. Anderson, Linnea Diep, Jason M. Goldstein and Tamie J. Chilcote. Their work appears in journals such as Journal of Neuroscience, Journal of Biological Chemistry, Nature, Neurology and American Journal Of Pathology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact